Pharmaceutical products. (30)
Pharmaceutical products. (statistical code 30): imports in August 2026 were JPY 415,796,216,000 (+23.5% year on year), quantity 6,063,224 KG, unit price JPY 67,792 per KG. Main origins: Ireland (20.7%), United States of America (15.8%), Germany (13.8%), Italy (6.6%), Switzerland (6.6%). Figures for August 2026 are preliminary.
Exports in the same month were JPY 101,494,602,000, a trade deficit of JPY 314,301,614,000. (imports: preliminary; exports: revised)
Export statistics for this code
Monthly statistics
| Month | Status | Import value | Quantity | Unit price | Year-on-year |
|---|---|---|---|---|---|
| August 2026 | preliminary | JPY 415,796,216,000 | 6,063,224 | JPY 67,792 | +23.5% |
| July 2026 | revised | JPY 465,020,665,000 | 7,032,341 | JPY 66,086 | +6.2% |
| June 2026 | revised | JPY 447,607,983,000 | 6,672,814 | JPY 66,411 | +9.5% |
| May 2026 | revised | JPY 466,642,446,000 | 6,966,725 | JPY 66,842 | +9.1% |
| April 2026 | revised | JPY 401,929,211,000 | 6,962,216 | JPY 57,685 | +11.4% |
| March 2026 | revised | JPY 457,799,510,000 | 7,070,718 | JPY 64,186 | +9.5% |
| February 2026 | revised | JPY 402,904,937,000 | 6,175,331 | JPY 64,738 | -3.7% |
| January 2026 | revised | JPY 331,360,428,000 | 5,921,458 | JPY 55,888 | -14.6% |
| December 2025 | revised (second) | JPY 441,276,297,000 | 5,941,671 | JPY 73,633 | +30.9% |
| November 2025 | revised (second) | JPY 432,785,071,000 | 6,409,110 | JPY 66,867 | +11.0% |
| October 2025 | revised (second) | JPY 339,920,281,000 | 6,600,233 | JPY 50,948 | -24.3% |
| September 2025 | revised (second) | JPY 467,798,369,000 | 6,473,497 | JPY 72,200 | +10.8% |
| August 2025 | revised (second) | JPY 336,706,826,000 | 5,312,348 | JPY 62,789 | -32.4% |
| July 2025 | revised (second) | JPY 438,067,883,000 | 7,589,914 | JPY 57,166 | -5.7% |
| June 2025 | revised (second) | JPY 408,597,828,000 | 7,122,418 | JPY 56,886 | +12.9% |
| May 2025 | revised (second) | JPY 427,907,277,000 | 6,917,134 | JPY 61,381 | +24.5% |
| April 2025 | revised (second) | JPY 360,953,576,000 | 6,639,985 | JPY 53,857 | +7.9% |
| March 2025 | revised (second) | JPY 418,120,223,000 | 6,440,038 | JPY 64,797 | +27.2% |
| February 2025 | revised (second) | JPY 418,560,169,000 | 6,428,885 | JPY 64,565 | +13.1% |
| January 2025 | revised (second) | JPY 388,046,724,000 | 7,429,488 | JPY 51,676 | +28.2% |
| December 2024 | final | JPY 337,178,515,000 | 6,216,867 | JPY 53,723 | -5.1% |
| November 2024 | final | JPY 389,840,588,000 | 5,262,517 | JPY 73,407 | -0.8% |
| October 2024 | final | JPY 448,933,986,000 | 7,211,008 | JPY 61,736 | +6.5% |
| September 2024 | final | JPY 422,356,331,000 | 6,323,811 | JPY 66,406 | +5.9% |
Subcategories
- Glands and other organs for organo -therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo -therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included.
- Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified.
- Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale.
- Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale.
- Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- Pharmaceutical goods specified in Note 4 to this Chapter.
- 30XX
Long-term trend (from 2022)
Imports in 2022 were JPY 5,192,672,893,000; in 2025, JPY 4,878,740,524,000, about 94% of the 2022 level.
| Year | Imports | Exports | Balance |
|---|---|---|---|
| 2026 (Jan–Aug) | JPY 3,389,061,396,000 | JPY 833,138,592,000 | deficit JPY 2,555,922,804,000 |
| 2025 | JPY 4,878,740,524,000 | JPY 1,250,117,744,000 | deficit JPY 3,628,622,780,000 |
| 2024 | JPY 4,602,220,419,000 | JPY 1,169,828,455,000 | deficit JPY 3,432,391,964,000 |
| 2023 | JPY 4,407,765,669,000 | JPY 1,071,641,687,000 | deficit JPY 3,336,123,982,000 |
| 2022 | JPY 5,192,672,893,000 | JPY 978,362,315,000 | deficit JPY 4,214,310,578,000 |
Some goods moved between chapters with the HS revisions of 1996, 2002, 2007, 2012, 2017 and 2022.
API and MCP
No API key required. An optional API key gives you a dedicated quota of 1,000 requests per day that is not affected by congestion (free at https://data.washutrading.com/register/).
Example API request for this item: https://data.washutrading.com/api/v1/series?code=30&flow=import